Phio Announces Data Showcasing INTASYL's Role in Helping Immune Cells Target and Kill Cancer Cells

. . Phio Announces Data Showcasing INTASYL's Role in Helping Immune Cells Target and Kill Cancer Cells October 07, 2024 8:00 AM EDT | Source: Phio Pharmaceuticals Corp. INTASYL compounds also improve the functionality and outcomes of adoptive cell therapies such as NK, TIL and CAR-T Marlborough, Massachusetts--(Newsfile Corp. - October 7, 2024) - Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a clinical stage biotechnology company whose proprietary INTASYL® siRNA gene silencing technology is designed to make im ...